MAJIDOVA, Nargiz et al. Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG). Turkish Journal of Gastroenterology, [S. l.], v. 36, n. 5, p. 293–301, 2025. DOI: 10.5152/tjg.2025.24784. Disponível em: https://turkjgastroenterol.org/index.php/tjg/article/view/4236. Acesso em: 1 jan. 2026.